The Pennant Group, Inc. (PNTG) is a Medical - Care Facilities company in the Healthcare sector, currently trading at $30.65. It has a SharesGrow Score of 65/100, indicating a above average investment profile with 3 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of PNTG = $35.68 (+16.4% from the current price, the stock appears undervalued). Analyst consensus target is PNTG = $39 (+27.2% upside).
Valuation: PNTG trades at a trailing Price-to-Earnings (P/E) of 36.6 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 1.97.
Financials: revenue is $948M, +26.3%/yr average growth. Net income is $30M, growing at +67%/yr. Net profit margin is 3.1% (thin). Gross margin is 12.9% (+0.5 pp trend).
Balance sheet: total debt is $453M against $333M equity (Debt-to-Equity (D/E) ratio 1.36, moderate). Current ratio is 1.14 (adequate). Debt-to-assets is 46.8%. Total assets: $968M.
Analyst outlook: 6 / 7 analysts rate PNTG as buy (86%) — strong consensus.
SharesGrow 7-Criteria breakdown: Value 48/100 (Partial), Growth 100/100 (Pass), Past 100/100 (Pass), Health 50/100 (Partial), Moat 38/100 (Fail), Future 88/100 (Pass), Income 30/100 (Fail).
